Profile | GDS4284 / 242625_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 233.647 | 52 |
GSM687648 | Patient 402 control | 257.384 | 53 |
GSM687653 | Patient 403 control | 181.423 | 48 |
GSM687658 | Patient 404 control | 5596.74 | 94 |
GSM687663 | Patient 411 control | 196.04 | 47 |
GSM687668 | Patient 422 control | 1028.3 | 74 |
GSM687673 | Patient 424 control | 4266.5 | 92 |
GSM687678 | Patient 425 control | 1197.86 | 76 |
GSM687683 | Patient 427 control | 874.519 | 71 |
GSM687688 | Patient 428 control | 144.882 | 42 |
GSM687695 | Patient 441 control | 6949.52 | 95 |
GSM687699 | Patient 443 control | 224.713 | 47 |
GSM687704 | Patient 444 control | 149.003 | 42 |
GSM687707 | Patient 448 control | 578.77 | 66 |
GSM687712 | Patient 449 control | 361.85 | 58 |
GSM687719 | Patient 450 control | 2339.97 | 86 |
GSM687724 | Patient 451 control | 1351.97 | 79 |
GSM687728 | Patient 452 control | 579.865 | 66 |
GSM687646 | Patient 401 treated 24h | 259.431 | 53 |
GSM687649 | Patient 402 treated 24h | 258.351 | 54 |
GSM687665 | Patient 411 treated 24h | 270.91 | 52 |
GSM687651 | Patient 402 treated 4 weeks | 210.651 | 48 |
GSM687667 | Patient 411 treated 4 weeks | 166.294 | 44 |
GSM687670 | Patient 422 treated 24h | 1204.67 | 76 |
GSM687671 | Patient 422 treated 4 weeks | 936.842 | 73 |
GSM687654 | Patient 403 treated 24h | 362.19 | 60 |
GSM687675 | Patient 424 treated 24h | 2636.27 | 87 |
GSM687685 | Patient 427 treated 24h | 920.188 | 73 |
GSM687656 | Patient 403 treated 4 weeks | 224.702 | 52 |
GSM687677 | Patient 424 treated 4 weeks | 2933.86 | 88 |
GSM687687 | Patient 427 treated 4 weeks | 190.398 | 49 |
GSM687692 | Patient 428 treated 4h | 395.902 | 60 |
GSM687716 | Patient 449 treated 4h | 202.38 | 50 |
GSM687722 | Patient 450 treated 4h | 2104.88 | 85 |
GSM687680 | Patient 425 treated 24h | 1021.35 | 74 |
GSM687690 | Patient 428 treated 24h | 323.977 | 58 |
GSM687700 | Patient 443 treated 24h | 1872.28 | 83 |
GSM687705 | Patient 444 treated 24h | 96.0281 | 35 |
GSM687714 | Patient 449 treated 24h | 433.056 | 62 |
GSM687721 | Patient 450 treated 24h | 3954.3 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 2034.12 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 437.541 | 62 |
GSM687702 | Patient 443 treated 4 weeks | 279.761 | 52 |
GSM687718 | Patient 449 treated 4 weeks | 610.565 | 67 |
GSM687723 | Patient 450 treated 4 weeks | 1059.62 | 75 |
GSM687661 | Patient 404 treated 4h | 3847.58 | 91 |
GSM687710 | Patient 448 treated 4h | 499.792 | 64 |
GSM687726 | Patient 451 treated 4h | 853.892 | 71 |
GSM687730 | Patient 452 treated 4h | 75.3008 | 18 |
GSM687660 | Patient 404 treated 24h | 25096.6 | 99 |
GSM687697 | Patient 441 treated 24h | 6629.93 | 95 |
GSM687709 | Patient 448 treated 24h | 712.635 | 69 |
GSM687725 | Patient 451 treated 24h | 1576.66 | 81 |
GSM687729 | Patient 452 treated 24h | 438.869 | 61 |
GSM687727 | Patient 451 treated 4 weeks | 2236.02 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 13617.8 | 98 |